Scleroderma - Prognosis

Prognosis

Individuals with morphea or limited scleroderma have a relatively positive outlook. They will rarely die from the scleroderma. Those with very widespread skin and organ involvement (systemic) have a negative prognosis. More women have scleroderma, but the disease kills more men. Following diagnosis, two-thirds of patients live at least 11 years. The higher the patient's age at diagnosis, the more likely he or she is to die from the disease.

People with scleroderma have very different life expectancies. Some — for example, those with limited or mild diffuse disease — can expect to live 20 to 50 years after diagnosis. Others with severe, rapidly progressive disease — a group which makes up less than 10% of the total number of patients with diffuse scleroderma — might have a 50% chance of a five-year survival.

Read more about this topic:  Scleroderma

Other articles related to "prognosis":

Breast Cancer Classification - Grade - Overall Grade
... The scores for each of these three criteria are added together to give a final overall score and a corresponding grade as follows 3-5 Grade 1 tumor (well-differentiated) ... Best prognosis ...
Prognosis - History
... For 19th century physicians, particularly those following the French school of medicine, the main aim of medicine was not to cure disease, but rather to give a medical diagnosis and achieve a satisfying prognosis of the patient's chances ... Only several decades later did the focus of efforts in Western medicine shift to curing disease ...
Mandibular Fracture - Prognosis
... The most common long-term complications are loss of sensation in the mandibular nerve, malocclusion and loss of teeth in the line of fracture ... The more complicated the fracture (infection, comminution, displacement) the higher the risk of fracture ...